Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis (Q34660324)

3 August 2017

title

Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis (English)

1 reference

https://api.crossref.org/works/10.2215/CJN.03800609

3 August 2017

Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis (English)

1 reference

focal segmental glomerulosclerosis

7 August 2024

main subject

1 reference

based on heuristic

inferred from title

idiopathic nephrotic syndrome

1 reference

3

Virginia J Savin

1 reference

3 August 2017

1

Ellen T McCarthy

1 reference

3 August 2017

Mukut Sharma

2

1 reference

3 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20966123

reference URL

7 August 2024

publication date

21 October 2010

1 reference

full work available at URL

3 August 2017

https://journals.lww.com/cjasn/Fulltext/2010/11000/Circulating_Permeability_Factors_in_Idiopathic.35.aspx

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20966123

reference URL

http://cjasn.asnjournals.org/cgi/content/abstract/5/11/2115

7 August 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20966123

reference URL

https://journals.lww.com/01277230-201011000-00035

7 August 2024

1 reference

https://api.crossref.org/works/10.2215/CJN.03800609

Clinical Journal of the American Society of Nephrology

7 August 2024

published in

1 reference

3 August 2017

volume

5

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

2115-2121

1 reference

Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children

3 August 2017

cites work

https://api.crossref.org/works/10.2215/CJN.03800609

2

1 reference

Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

3

1 reference

Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

4

1 reference

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

5

1 reference

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

6

1 reference

Differential risk of remission and ESRD in childhood FSGS.

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

7

1 reference

Focal and segmental glomerulosclerosis: definition and relevance of a partial remission

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

8

1 reference

A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

9

1 reference

Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

10

1 reference

Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

11

1 reference

Protease activity of plasma hemopexin

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

12

1 reference

Altered activity of plasma hemopexin in patients with minimal change disease in relapse

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

13

1 reference

Modification of kidney barrier function by the urokinase receptor.

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

15

1 reference

Urinary CD80 excretion increases in idiopathic minimal-change disease

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

16

1 reference

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

17

1 reference

Recurrence of idiopathic nephrotic syndrome after renal transplantation

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

18

1 reference

Recurrent focal glomerulosclerosis: natural history and response to therapy

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

19

1 reference

Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

20

1 reference

Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

21

1 reference

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

22

1 reference

Cyclosporine protects glomeruli from FSGS factor via an increase in glomerular cAMP

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

23

1 reference

Serial Estimates of Serum Permeability Activity and Clinical Correlates in Patients with Native Kidney Focal Segmental Glomerulosclerosis

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

24

1 reference

Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

25

1 reference

Renal transplantation in primary focal segmental glomerulosclerosis using a tolerance induction protocol

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

26

1 reference

Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

27

1 reference

Proteinuria after injection of human focal segmental glomerulosclerosis factor

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

28

1 reference

Proteinuria in rats induced by serum from patients with collapsing glomerulopathy.

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

29

1 reference

Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

30

1 reference

Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

31

1 reference

The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects.

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

32

1 reference

Permeability factors in focal segmental glomerulosclerosis

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

33

1 reference

Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

34

1 reference

Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

35

1 reference

Glomerular albumin permeability as anin vitromodel for characterizing the mechanism of focal glomerulosclerosis and predicting post-transplant recurrence

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

37

1 reference

Measurement of albumin reflection coefficient with isolated rat glomeruli

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

38

1 reference

Alteration of glomerular permeability to macromolecules induced by cross-linking of beta 1 integrin receptors

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

40

1 reference

Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (P(alb))

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

41

1 reference

Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

42

1 reference

Effect of superoxide exposure on albumin permeability of isolated rat glomeruli

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

43

1 reference

Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

46

1 reference

Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

49

1 reference

Posttransplant Recurrence of Proteinuria in a Case of Focal Segmental Glomerulosclerosis Associated with WT1 Mutation

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

50

1 reference

Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

51

1 reference

Plasma "factors" in recurrent nephrotic syndrome after kidney transplantation: causes or consequences of glomerular injury?

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

52

1 reference

8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier.

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

53

1 reference

Nitric oxide preserves the glomerular protein permeability barrier by antagonizing superoxide

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

54

1 reference

Inhibitory effect of Tripterygium wilfordii multiglycoside on increased glomerular albumin permeability in vitro

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

55

1 reference

Cyclosporine prevents the increase in glomerular albumin permeability caused by serum from patients with focal segmental glomerular sclerosis

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

56

1 reference

Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

57

1 reference

Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

58

1 reference

Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

59

1 reference

Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

60

1 reference

FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy

7 August 2024

https://api.crossref.org/works/10.2215/CJN.03800609

61

1 reference

7 August 2024

Identifiers

DOI

10.2215/CJN.03800609

1 reference

3 August 2017

1 reference